Koa Shoji Holdings Co.,Ltd. (9273.T)
JPY 704.0
(0.0%)
JPY 704.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 4.38 Billion JPY | 3.11% |
| 2022 | 4.24 Billion JPY | 11.62% |
| 2021 | 3.8 Billion JPY | 12.74% |
| 2020 | 3.37 Billion JPY | 44.96% |
| 2019 | 2.32 Billion JPY | 92.42% |
| 2018 | 1.21 Billion JPY | -4.97% |
| 2017 | 1.27 Billion JPY | -21.09% |
| 2016 | 1.61 Billion JPY | -7.8% |
| 2015 | 1.75 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q3 | 1.17 Billion JPY | -1.79% |
| 2023 Q4 | 814.3 Million JPY | -30.68% |
| 2023 Q1 | 1.19 Billion JPY | 22.93% |
| 2023 FY | 4.38 Billion JPY | 3.11% |
| 2023 Q2 | 1.19 Billion JPY | -0.08% |
| 2022 Q4 | 973.82 Million JPY | -12.73% |
| 2022 FY | 4.24 Billion JPY | 11.62% |
| 2022 Q1 | 1.01 Billion JPY | 33.95% |
| 2022 Q2 | 1.14 Billion JPY | 12.81% |
| 2022 Q3 | 1.11 Billion JPY | -2.55% |
| 2021 FY | 3.8 Billion JPY | 12.74% |
| 2021 Q4 | 757.8 Million JPY | -14.13% |
| 2021 Q3 | 882.45 Million JPY | -31.94% |
| 2021 Q2 | 1.29 Billion JPY | 48.94% |
| 2021 Q1 | 870.53 Million JPY | 1.45% |
| 2020 Q2 | 907.57 Million JPY | 32.36% |
| 2020 Q1 | 685.67 Million JPY | -17.12% |
| 2020 FY | 3.37 Billion JPY | 44.96% |
| 2020 Q4 | 858.1 Million JPY | -7.32% |
| 2020 Q3 | 925.86 Million JPY | 2.02% |
| 2019 Q2 | 799.6 Million JPY | 643.84% |
| 2019 Q4 | 827.33 Million JPY | 38.96% |
| 2019 Q3 | 595.38 Million JPY | -25.54% |
| 2019 FY | 2.32 Billion JPY | 92.42% |
| 2019 Q1 | 107.49 Million JPY | -82.97% |
| 2018 Q3 | 220.79 Million JPY | 8.99% |
| 2018 Q1 | 156.05 Million JPY | -59.93% |
| 2018 FY | 1.21 Billion JPY | -4.97% |
| 2018 Q4 | 631.36 Million JPY | 185.96% |
| 2018 Q2 | 202.57 Million JPY | 29.81% |
| 2017 FY | 1.27 Billion JPY | -21.09% |
| 2017 Q4 | 389.47 Million JPY | 0.0% |
| 2017 Q3 | - JPY | 0.0% |
| 2016 FY | 1.61 Billion JPY | -7.8% |
| 2015 FY | 1.75 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | 14.291% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 97.953% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 101.237% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 97.444% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 2341.467% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | 86.037% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | 53.933% |
| Eisai Co., Ltd. | 53.4 Billion JPY | 91.795% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -512.055% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | 66.717% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | 24.482% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | -123.132% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 987.108% |
| Tsumura & Co. | 20.01 Billion JPY | 78.108% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | -9.094% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | 12.98% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | 75.168% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | -13.59% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | 54.899% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | 27.119% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 242.329% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | -12.54% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 639.915% |
| MedRx Co., Ltd | -933 Million JPY | 569.702% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | 14.939% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 484.751% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 284.908% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | 32.58% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | 76.796% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 728.346% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | 77.33% |